Café

© 2026 Longbridge｜Terms of Service Privacy Policy

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

Unusual Whales

Aug 3, 2026 at 06:03 AM

In the second quarter of 2026, the global revenue reached around $240 million, with BRIUMVI U.S. net product revenue contributing about $228 million to this total.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

TG Therap

TGTX.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--

LongbridgeAI